Report updated Apr 22, 2026
STABLEize for HealthStream
For neonatal healthcare professionals, including nurses, physicians, and therapists, who require specialized stabilization care references.
STABLEize for HealthStream is an established medical app that is a paid app. With a 5.0/5 rating from 1 reviews, it shows polarized user reception.
What is STABLEize for HealthStream?
Current Momentum
v1.1 · 2w ago
MaintenanceSTABLEize for HealthStream updated to the 7th edition S.T.A.B.L.E. Program modules, including new treatment guidelines and clinical calculators. The app is currently in maintenance mode.
Active Nemesis
Medscape
By WebMD
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Comprehensive bedside reference for Sugar, Temperature, Airway, Blood pressure, Lab work, and Emotional support.
22 severe congenital heart disease anomalies featuring MP4 animations of blood flow and palliative procedures.
Tools for corrected gestational age, temperature conversion, catheter insertion depth, and weight conversion.
Includes neuroprotective hypothermia checklists, neurologic exams, and dopamine hydrochloride mixing instructions.
How much does it cost?
- Enterprise/Institutional purchase required via HealthStream
The app is strictly B2B; it is not a consumer-facing product but a professional tool provided to employees of organizations that have purchased the S.T.A.B.L.E. program.
Who Built It?
The STABLE Program
Providing neonatal healthcare professionals with evidence-based stabilization guidelines and clinical decision support tools at the bedside.
Portfolio
2
Apps
What other apps does The STABLE Program make?
Explore the full The STABLE Program report
Portfolio breakdown, audience, momentum, and every app published by The STABLE Program.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for STABLEize for HealthStream?
How's The Medical Market?
Market outlook for this category
Available very soon
The rivals identified
The outtake for STABLEize for HealthStream
Strengths to defend, gaps to attack
Core Strengths
- Proprietary MP4 cardiac animations for physiological clarity
- Direct alignment with the industry-standard S.T.A.B.L.E. Program
- Institutional lock-in via HealthStream integration
Critical Frictions
- Android version lags behind iOS update cycle (Nov 2025 vs April 2026)
- Lack of a comprehensive drug formulary or interaction checker
- Gated access prevents use by non-institutional clinicians
Growth Levers
- Integration with hospital EHR systems (Epic/Cerner) for faster access
- Expansion of visual procedure guides to Airway and Lab modules
- Development of offline-first search capabilities
Market Threats
- Broad clinical tools like Medscape adding specialized neonatal modules
- UpToDate's deep institutional penetration and EHR integration
- Clinical guidelines in the app falling behind the latest literature
What are the next best moves?
Synchronize Android version to v1.1.2
The Android version is currently on a 2025 build, missing the 7th edition updates and PGE1 dosing available on iOS (April 2026).
Evaluate a neonatal-specific drug formulary integration
Competitors like Medscape and Harriet Lane include formularies; their absence in STABLEize forces users to switch apps during bedside care.
Develop EHR deep-linking capabilities
UpToDate (Contender) uses EHR integration to drive usage; STABLEize's standalone nature is a friction point for hospital-based clinicians.
Feature Gaps vs Competitors
- Drug interaction checker and formulary (available in Medscape)
- EHR system integration (available in UpToDate)
- Comprehensive pediatric scope including toxicology (available in Harriet Lane Handbook)
Key Takeaways
STABLEize is a high-authority niche tool whose value is anchored in its unique cardiac animations and S.T.A.B.L.E. Program branding. However, its utility is limited by the lack of a drug formulary and a lagging Android update cycle, which risks losing users to broader clinical references like Medscape.
Where Is It Heading?
Stable
v1.1.2 added 7th edition modules and PGE1 dosing (April 2026) — indicates active clinical maintenance.
Android version has not been updated since Nov 2025 — creates a feature gap for non-iOS users.